Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $222.2 million.

  • Ultralife's Liabilities and Shareholders Equity rose 2888.31% to $222.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $887.4 million, marking a year-over-year increase of 2657.7%. This contributed to the annual value of $220.5 million for FY2024, which is 2365.71% up from last year.
  • Ultralife's Liabilities and Shareholders Equity amounted to $222.2 million in Q3 2025, which was up 2888.31% from $221.0 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Liabilities and Shareholders Equity ranged from a high of $223.8 million in Q1 2025 and a low of $136.4 million during Q1 2021
  • Moreover, its 4-year median value for Liabilities and Shareholders Equity was $175.8 million (2023), whereas its average is $180.1 million.
  • Per our database at Business Quant, Ultralife's Liabilities and Shareholders Equity crashed by 667.81% in 2021 and then skyrocketed by 3011.71% in 2025.
  • Over the past 4 years, Ultralife's Liabilities and Shareholders Equity (Quarter) stood at $136.8 million in 2021, then skyrocketed by 30.31% to $178.3 million in 2023, then increased by 23.66% to $220.5 million in 2024, then grew by 0.81% to $222.2 million in 2025.
  • Its last three reported values are $222.2 million in Q3 2025, $221.0 million for Q2 2025, and $223.8 million during Q1 2025.